Stockreport

Therapix shares jump 30% premarket on news of positive Tourette syndrome trial [MarketWatch]

THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE  (TRPX) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/trpx
PDF Therapix shares surge 30% premarket on news of positive trial of Tourette syndrome treatment Therapix Biosciences Ltd. shares TRPX, -7.00% soared more than 30% in pre [Read more]